Raymond James Financial’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Sell
53,227
-800
-1% -$4.46K ﹤0.01% 4698
2026
Q1
$211K Sell
54,027
-2,250
-4% -$9.99K ﹤0.01% 4860
2025
Q4
$256K Sell
56,277
-1,087
-2% -$5.58K ﹤0.01% 4667
2025
Q3
$352K Sell
57,364
-200
-0.3% -$1.26K ﹤0.01% 4318
2025
Q2
$373K Sell
57,564
-1,357
-2% -$7.31K ﹤0.01% 4173
2025
Q1
$313K Buy
58,921
+2,053
+4% +$14K ﹤0.01% 4196
2024
Q4
$478K Buy
+56,868
New +$439K ﹤0.01% 3937

Other funds holding TBI

Raymond James Financial's TBI Position: Q2 2026 in Review

Raymond James Financial reduced its Trueblue (TBI) stake by 1.5% in Q2 2026, selling an estimated $4.46K and leaving 53,227 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #4698.

Raymond James Financial first reported a position in TBI in Q4 2024 and has held it in 7 quarters since. The position peaked at $478K in Q4 2024. 113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Raymond James Financial held 53,227 shares of Trueblue worth $371K as of Q2 2026.
  • Raymond James Financial sold 800 Trueblue shares in Q2 2026, an estimated $4.46K.
  • Trueblue made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4698 holding.
  • Raymond James Financial first reported a position in Trueblue in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Trueblue position peaked at $478K in Q4 2024.
  • 113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.